top of page
29 avr. 2020
Bone Therapeutics secured €11 million in mixed financing—including bridge loans, equity, and a flexible convertible bond facility—to advance its late-stage ALLOB and JTA-004 programs through upcoming clinical milestones.
Gosselies, Belgium, 29 April 2020 - Bone Therapeutics secured €11 million in mixed financing—including bridge loans, equity, and a flexible convertible bond facility—to advance its late-stage ALLOB and JTA-004 programs through upcoming clinical milestones.
Dowload Bone Therapeutics press release
bottom of page